跳至主要内容
临床试验/NCT06037707
NCT06037707已完成不适用

Incidence of Thromboembolism in COVID-19 Infection in the ICU: a Retrospective Cohort Analysis

Ayse Zeynep Turan1 个研究点 分布在 1 个国家目标入组 484 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
484
试验地点
1
主要终点
Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease

研究概览

简要总结

The present study aims to determine frequency of thromboembolic complications and the underlying causes of this complication of the patients who admitted to the intensive care unit diagnosed with COVID-19.

详细描述

Patients diagnosed with COVID-19 infection and admitted to the ICU were recruited. Demographic information, comorbidities, length of ICU stay, some laboratory data,thromboembolic complications of the patients were recorded.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who were infected with COVID-19 and admitted to the intensive care unit between the time of March 2020-December 2021

排除标准

  • who is under 18 years old.

结局指标

主要结局

Rate of thromboembolic complications among patients who effected from different variants of COVID-19 Disease

时间窗: During the entire intensive care stay up to 1 day

Both arterial and venous thromboembolic events were detected

次要结局

  • Rate of thromboembolic complications of COVID-19 disease in critically ill patients(During the entire intensive care stay up to 1 day)
  • What is the rate of thromboembolism according to the comorbidities(During the entire intensive care stay up to 1 day)
  • Rate of thromboembolic complications according to anticoagulant therapy(During the entire intensive care stay up to 1 day)

研究者

发起方
Ayse Zeynep Turan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ayse Zeynep Turan

Principle Investigator

Derince Training and Research Hospital

研究点 (1)

Loading locations...

相似试验